Placeholder

Genomic Innovation

$30.00

Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at mwalsh@pharmavoice.com.

Product Description

Our understanding of disease and biology is growing every day, giving researchers even more power to develop new and better medicines. The area of genetics is taking off, industry experts say. The ability to sequence individual genomes and the genomes of diseases is providing new avenues of research and new ways to target patients.
This will impact pharma companies in a number of ways. The first is the ability to accurately determine the cause of disease and genes that might be involved, and this can help companies find targets to develop drugs against. The second is around selective biomarkers to provide information about which patients are likely to benefit. These data can then be used for selection…

FEEDBACK